Physician

Daniel H. Shevrin, MD

According to 2025 Medicare claims, Daniel Shevrin, MD (NPI: 1689607152) practices medical oncology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is ENDEAVOR HEALTH MEDICAL GROUP (NPI: 1497701882; TIN: 363738206) and primary practice location at 60026-1339.

Shevrin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 352 traditional Medicare patients, billed 1,182 HCPCS/CPT codes, and received $95,910 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,431 prescription claims across 161 beneficiaries totaling $4,734,755 in drug costs, led by Erleada (Apalutamide). Open Payments data shows 14 records totaling $53,645. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $3,187,885 and ending at $4,734,755. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	392	1,622	$99,547
2016	399	1,685	$103,893
2017	401	1,647	$102,062
2018	390	1,711	$104,790
2019	376	1,509	$92,577
2020	346	1,400	$80,781
2021	336	1,390	$102,616
2022	329	1,259	$87,872
2023	352	1,266	$91,514
2024	352	1,182	$95,910

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	143	1,307	$3,187,885
2016	143	1,268	$4,130,451
2017	172	1,342	$5,308,872
2018	178	1,435	$5,459,478
2019	156	1,557	$4,989,550
2020	176	1,487	$3,180,517
2021	157	1,525	$3,788,524
2022	159	1,323	$3,804,433
2023	160	1,300	$3,705,096
2024	161	1,431	$4,734,755

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	63	112	$126
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	28	28	$110
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	209	624	$81
99442	Telephone medical discussion with physician, 11-20 minutes	27	33	$62
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	138	278	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erleada	Apalutamide	106	3,840	$1,791,376
Xtandi	Enzalutamide	98	3,180	$982,396
Nubeqa	Darolutamide	35	1,050	$477,137
Abiraterone Acetate	Abiraterone Acetate	424	14,445	$380,635
Cabometyx	Cabozantinib S-Malate	13	370	$277,241

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	14	$53,645	NORTHSHORE UNIVERSITY HEALTHSYSTEM
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel H. Shevrin, MD?

Tedicare shows public-source Medicare data for Daniel H. Shevrin, MD (NPI 1689607152), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel H. Shevrin, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel H. Shevrin, MD?

Daniel H. Shevrin, MD is linked to ENDEAVOR HEALTH MEDICAL GROUP (billing NPI 1497701882) in the available physician profile data.

Does Daniel H. Shevrin, MD have Open Payments data?

Daniel H. Shevrin, MD has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.